DaVita (DVA) Financials: Revenue & Earnings
DVA$191.76+7.83 +4.26%
$12.23B
Market Cap
15.82
P/E
12.94
Forward P/E
62
Score
DaVita (DVA) Financials: Revenue & Earnings
DVA price $191.76 +7.83 +4.26%
- Ticker
- DVA
- Price
- $191.76
- Change
- +7.83 +4.26%
- Market cap ?
- $12.23B
- P/E ?
- 15.82
- Forward P/E ?
- 12.94
- Dividend yield ?
- 0.00%
- Beta ?
- 0.80
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Stocklytics score
- 62
- Value
- 75
- Quality
- 53
- Growth
- 58
Stocklytics score rationale: value 75, quality 53, growth 58.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 14745105000 | 10876634000 | 11404851000 | 11388479000 | 11550604000 | 11618797000 | 11609894000 | 12140147000 | 12815550000 | 13643069000 |
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic…
Earnings and financials
DaVita Inc. (DVA) trades at $191.76, with a market cap of $12.23B and a trailing P/E of 15.82. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 14745105000 | 10876634000 | 11404851000 | 11388479000 | 11550604000 | 11618797000 | 11609894000 | 12140147000 | 12815550000 | 13643069000 |
Insights · Dividends · Forecast · Financials · Learn